Cargando…
Phase II study of docetaxel in combination with epirubicin and protracted venous infusion 5-fluorouracil (ETF) in patients with recurrent or metastatic breast cancer. A Yorkshire breast cancer research group study
This study was originally designed as a phase I/II study, with a dose escalation of docetaxel in combination with epirubicin 50 mg m(−2) and 5-fluorouracil (5-FU) 200 mg m(−2) day(−1). However, as dose escalation was not possible, the study is reported as a phase II study of the combination to asses...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409488/ https://www.ncbi.nlm.nih.gov/pubmed/15150554 http://dx.doi.org/10.1038/sj.bjc.6601840 |